Segment Information (Tables)
|
6 Months Ended |
Jun. 30, 2020 |
Segment Reporting [Abstract] |
|
Schedule of reportable business segment information |
Reportable business segment information is as follows (dollar amounts in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
|
|
Six Months Ended June 30, |
|
|
|
2020 |
|
2019 |
|
2020 |
|
2019 |
Net sales: |
|
|
|
|
|
|
|
Asia |
$ |
32,757 |
|
|
$ |
35,162 |
|
|
$ |
63,715 |
|
|
$ |
68,758 |
|
Europe |
15,465 |
|
|
15,075 |
|
|
36,092 |
|
|
30,672 |
|
North America |
34,471 |
|
|
34,620 |
|
|
73,228 |
|
|
71,143 |
|
Latin America and Other |
4,593 |
|
|
5,867 |
|
|
10,177 |
|
|
11,423 |
|
Total net sales |
87,286 |
|
|
90,724 |
|
|
183,212 |
|
|
181,996 |
|
|
|
|
|
|
|
|
|
Contribution margin (1): |
|
|
|
|
|
|
|
Asia |
16,052 |
|
|
16,677 |
|
|
30,579 |
|
|
32,402 |
|
Europe |
5,202 |
|
|
4,886 |
|
|
12,033 |
|
|
9,827 |
|
North America |
11,904 |
|
|
11,625 |
|
|
26,323 |
|
|
25,418 |
|
Latin America and Other |
1,946 |
|
|
2,369 |
|
|
4,396 |
|
|
4,740 |
|
Total contribution margin |
35,104 |
|
|
35,557 |
|
|
73,331 |
|
|
72,387 |
|
|
|
|
|
|
|
|
|
Selling, general and administrative expenses (2) |
28,504 |
|
|
31,019 |
|
|
59,569 |
|
|
64,871 |
|
Operating income |
6,600 |
|
|
4,538 |
|
|
13,762 |
|
|
7,516 |
|
|
|
|
|
|
|
|
|
Other income (loss), net |
1,509 |
|
|
306 |
|
|
(901) |
|
|
258 |
|
Income before provision for income taxes |
$ |
8,109 |
|
|
$ |
4,844 |
|
|
$ |
12,861 |
|
|
$ |
7,774 |
|
_________________________________________
(1) Contribution margin consists of net sales less cost of sales and volume incentives expense.
(2) Service fees in China totaled $2.9 million and $4.8 million for the three and six-month periods ended June 30, 2020, respectively, compared to $2.3 million and $4.5 million for the three and six-month periods ended June 30, 2019. These service fees are included in selling, general and administrative expenses.
|
Schedule of consolidated net sales revenue by geographical locations |
From an individual country perspective, the United States and South Korea comprise 10 percent or more of consolidated net sales for the three and six-month periods ended June 30, 2020 and 2019, as follows (dollar amounts in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
|
|
Six Months Ended June 30, |
|
|
|
2020 |
|
2019 |
|
2020 |
|
2019 |
Net sales: |
|
|
|
|
|
|
|
United States |
$ |
32,147 |
|
|
$ |
32,194 |
|
|
$ |
67,986 |
|
|
$ |
66,155 |
|
South Korea |
14,466 |
|
|
18,923 |
|
|
30,855 |
|
|
37,451 |
|
Other |
40,673 |
|
|
39,607 |
|
|
84,371 |
|
|
78,390 |
|
|
$ |
87,286 |
|
|
$ |
90,724 |
|
|
$ |
183,212 |
|
|
$ |
181,996 |
|
|
Schedule of revenue generated by each of the Company's product lines |
Net sales generated by each of our product lines is set forth below (dollar amounts in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
|
|
Six Months Ended June 30, |
|
|
|
2020 |
|
2019 |
|
2020 |
|
2019 |
Asia |
|
|
|
|
|
|
|
General health |
$ |
8,263 |
|
|
$ |
10,752 |
|
|
$ |
17,309 |
|
|
$ |
18,836 |
|
Immune |
179 |
|
|
199 |
|
|
380 |
|
|
357 |
|
Cardiovascular |
9,323 |
|
|
11,561 |
|
|
18,662 |
|
|
23,394 |
|
Digestive |
8,391 |
|
|
7,333 |
|
|
14,547 |
|
|
12,108 |
|
Personal care |
1,877 |
|
|
1,820 |
|
|
4,882 |
|
|
6,087 |
|
Weight management |
4,724 |
|
|
3,497 |
|
|
7,935 |
|
|
7,976 |
|
|
32,757 |
|
|
35,162 |
|
|
63,715 |
|
|
68,758 |
|
Europe |
|
|
|
|
|
|
|
General health |
$ |
6,816 |
|
|
$ |
5,372 |
|
|
$ |
14,776 |
|
|
$ |
11,120 |
|
Immune |
1,370 |
|
|
1,090 |
|
|
3,814 |
|
|
2,363 |
|
Cardiovascular |
2,215 |
|
|
2,766 |
|
|
5,112 |
|
|
5,617 |
|
Digestive |
3,781 |
|
|
3,550 |
|
|
8,713 |
|
|
7,181 |
|
Personal care |
718 |
|
|
1,661 |
|
|
2,469 |
|
|
3,160 |
|
Weight management |
565 |
|
|
636 |
|
|
1,208 |
|
|
1,231 |
|
|
15,465 |
|
|
15,075 |
|
|
36,092 |
|
|
30,672 |
|
North America |
|
|
|
|
|
|
|
General health |
$ |
14,887 |
|
|
$ |
14,934 |
|
|
$ |
30,351 |
|
|
$ |
30,682 |
|
Immune |
5,049 |
|
|
3,340 |
|
|
12,847 |
|
|
7,558 |
|
Cardiovascular |
3,679 |
|
|
4,935 |
|
|
7,846 |
|
|
10,011 |
|
Digestive |
7,858 |
|
|
8,523 |
|
|
16,099 |
|
|
17,244 |
|
Personal care |
1,975 |
|
|
1,598 |
|
|
3,904 |
|
|
2,946 |
|
Weight management |
1,023 |
|
|
1,290 |
|
|
2,181 |
|
|
2,702 |
|
|
34,471 |
|
|
34,620 |
|
|
73,228 |
|
|
71,143 |
|
Latin America and Other |
|
|
|
|
|
|
|
General health |
$ |
1,350 |
|
|
$ |
1,783 |
|
|
$ |
2,964 |
|
|
$ |
3,395 |
|
Immune |
380 |
|
|
602 |
|
|
1,489 |
|
|
1,210 |
|
Cardiovascular |
263 |
|
|
361 |
|
|
641 |
|
|
700 |
|
Digestive |
2,264 |
|
|
2,645 |
|
|
4,326 |
|
|
5,181 |
|
Personal care |
212 |
|
|
260 |
|
|
464 |
|
|
517 |
|
Weight management |
124 |
|
|
216 |
|
|
293 |
|
|
420 |
|
|
4,593 |
|
|
5,867 |
|
|
10,177 |
|
|
11,423 |
|
|
$ |
87,286 |
|
|
$ |
90,724 |
|
|
$ |
183,212 |
|
|
$ |
181,996 |
|
|
Schedule of consolidated property, plant and equipment by geographical locations |
From an individual country perspective, only the United States comprised 10 percent or more of consolidated property, plant and equipment as follows (dollar amounts in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
June 30, 2020 |
|
December 31, 2019 |
Property, plant and equipment: |
|
|
|
United States |
$ |
52,467 |
|
|
$ |
54,470 |
|
Other |
4,220 |
|
|
5,042 |
|
Total property, plant and equipment, net |
$ |
56,687 |
|
|
$ |
59,512 |
|
|
Schedule of assets per segment |
Total assets per segment is set forth below (dollar amounts in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
June 30, 2020 |
|
December 31, 2019 |
Assets: |
|
|
|
Asia |
$ |
72,608 |
|
|
$ |
65,959 |
|
Europe |
17,952 |
|
|
15,187 |
|
North America |
128,358 |
|
|
124,337 |
|
Latin America and Other |
8,011 |
|
|
7,585 |
|
Total assets |
$ |
226,929 |
|
|
$ |
213,068 |
|
|